VANCOUVER, May 3 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , will webcast its conference call discussing financial results for the first quarter ended March 31st, 2004 on Monday, May 10th, 2004 at 2:00 PM PST (5:00 PM EST).
The webcast will be available to all interested parties through Angiotech’s website (http://www.angiotech.com/) under Investor Relations or by dialing toll-free at (888) 343-7141. To ensure a timely connection to the webcast it is recommended that users register approximately 15 minutes before the conference call. Please note this is an analyst call and at the end of the presentation we will invite questions from the analysts only. A recording of the call will be available until May 17th, 2004 by calling (800) 558-5253 and entering Access Code 21194339. A press release will be issued prior to the conference call.
The conference call will be hosted by William Hunter, President and Chief Executive Officer, and David Hall, Chief Financial Officer.
The webcast will be available for seven days on the Angiotech website.
Vancouver-based Angiotech Pharmaceuticals, Inc. is dedicated to enhancing the performance of medical devices and biomaterials through the innovative uses of pharmacotherapeutics. To find out more about Angiotech Pharmaceuticals, Inc. , visit our website at http://www.angiotech.com/.
For more information contact: Media: Eric Starkman Starkman & Associates (212) 252-8545 Analysts: Rui Avelar Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6996 Investors: Ian Harper Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6933
Angiotech Pharmaceuticals, Inc.
CONTACT: Media: Eric Starkman, Starkman & Associates, (212) 252-8545;Analysts: Rui Avelar, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext6996; Investors: Ian Harper, Angiotech Pharmaceuticals, Inc., (604) 221-7676ext 6933
